Lorraine E. Chalifour

1.9k total citations
68 papers, 1.5k citations indexed

About

Lorraine E. Chalifour is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lorraine E. Chalifour has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lorraine E. Chalifour's work include Effects and risks of endocrine disrupting chemicals (11 papers), Estrogen and related hormone effects (7 papers) and Biotin and Related Studies (6 papers). Lorraine E. Chalifour is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (11 papers), Estrogen and related hormone effects (7 papers) and Biotin and Related Studies (6 papers). Lorraine E. Chalifour collaborates with scholars based in Canada, United States and Australia. Lorraine E. Chalifour's co-authors include Lesley Alpert, Nacéra Saadane, Igal A. Sebag, Bhavini Patel, K. Dakshinamurti, Mohamad Raad, D O Wirak, Heather B. Miller, Jiang Li and Krishnamurti Dakshinamurti and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and The Journal of Immunology.

In The Last Decade

Lorraine E. Chalifour

67 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorraine E. Chalifour Canada	25	772	268	263	221	177	68	1.5k
P Hunt United States	23	510 0.7×	126 0.5×	140 0.5×	148 0.7×	102 0.6×	45	2.2k
Theodore E. Whitmore United States	19	566 0.7×	285 1.1×	307 1.2×	169 0.8×	48 0.3×	28	2.3k
Magnus R. Dias‐da‐Silva Brazil	22	865 1.1×	282 1.1×	327 1.2×	302 1.4×	46 0.3×	100	1.8k
Nina Horn Denmark	33	1.5k 1.9×	717 2.7×	142 0.5×	305 1.4×	96 0.5×	88	3.1k
Anastasia Andringa United States	17	992 1.3×	67 0.3×	104 0.4×	136 0.6×	129 0.7×	35	1.6k
Hideyuki Tanaka Japan	18	465 0.6×	73 0.3×	127 0.5×	88 0.4×	176 1.0×	137	1.3k
G. L. Prasad United States	21	907 1.2×	111 0.4×	287 1.1×	50 0.2×	402 2.3×	60	1.7k
Roger T. Worrell United States	27	1.5k 2.0×	60 0.2×	186 0.7×	177 0.8×	93 0.5×	49	2.5k
T. Tønnesen Denmark	17	729 0.9×	273 1.0×	60 0.2×	198 0.9×	131 0.7×	43	1.5k
Mary J. Cismowski United States	23	1.2k 1.5×	58 0.2×	239 0.9×	73 0.3×	318 1.8×	38	1.8k

Countries citing papers authored by Lorraine E. Chalifour

Since Specialization

Citations

This map shows the geographic impact of Lorraine E. Chalifour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine E. Chalifour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine E. Chalifour more than expected).

Fields of papers citing papers by Lorraine E. Chalifour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine E. Chalifour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine E. Chalifour. The network helps show where Lorraine E. Chalifour may publish in the future.

Co-authorship network of co-authors of Lorraine E. Chalifour

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine E. Chalifour. A scholar is included among the top collaborators of Lorraine E. Chalifour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine E. Chalifour. Lorraine E. Chalifour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moussa, Mahmoud, et al.. (2025). Botulinum toxin (A)-induced bone loss is associated with increased blood velocity and reduced vascular bone porosity. Journal of Bone and Mineral Research. 40(12). 1370–1384. 1 indexed citations

Marić, Milan, et al.. (2023). Exposure to the non-phthalate plasticizer di-heptyl succinate is less disruptive to C57bl/6N mouse recovery from a myocardial infarction than DEHP, TOTM or related di-octyl succinate. PLoS ONE. 18(7). e0288491–e0288491. 3 indexed citations

Barbat‐Artigas, Sébastien, Chulmin Cho, Huashan Peng, et al.. (2017). A Novel Egr-1-Agrin Pathway and Potential Implications for Regulation of Synaptic Physiology and Homeostasis at the Neuromuscular Junction. Frontiers in Aging Neuroscience. 9. 258–258. 11 indexed citations

Lee, Jun Seong, et al.. (2017). From the Cover: Lifelong Exposure of C57bl/6n Male Mice to Bisphenol A or Bisphenol S Reduces Recovery From a Myocardial Infarction. Toxicological Sciences. 159(1). 189–202. 26 indexed citations

Patel, Bhavini, Mohamad Raad, Igal A. Sebag, & Lorraine E. Chalifour. (2015). Sex-specific cardiovascular responses to control or high fat diet feeding in C57bl/6 mice chronically exposed to bisphenol A.. Toxicology Reports. 2. 1310–1318. 20 indexed citations

Paliouras, Miltiadis, Lenore K. Beitel, Bruce Gottlieb, et al.. (2015). Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe. Atherosclerosis. 246. 78–86. 5 indexed citations

Patel, Bhavini, Mohamad Raad, Igal A. Sebag, & Lorraine E. Chalifour. (2013). Lifelong Exposure to Bisphenol A Alters Cardiac Structure/Function, Protein Expression, and DNA Methylation in Adult Mice. Toxicological Sciences. 133(1). 174–185. 99 indexed citations

Rivas, Daniel, et al.. (2009). Alendronate affects calcium dynamics in cardiomyocytes in vitro. Vascular Pharmacology. 51(5-6). 350–358. 23 indexed citations

Gottlieb, Bruce, et al.. (2009). BAK1 gene variation and abdominal aortic aneurysms. Human Mutation. 30(7). 1043–1047. 22 indexed citations

10.

Komarova, Svetlana V., et al.. (2008). Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovascular Research. 81(4). 695–702. 27 indexed citations

11.

Copland, Ian B., Jessica Cuerquis, Daniel L. Coutu, et al.. (2008). Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia. American Journal of Physiology-Renal Physiology. 295(2). F488–F496. 28 indexed citations

12.

Mwale, F., et al.. (2008). Effect of Dexrazoxane and Amifostine on the Vertebral Bone Quality of Doxorubicin Treated Male Rats. The Open Orthopaedics Journal. 2(1). 115–120. 5 indexed citations

13.

Mwale, F., Caroline N. Demers, John Antoniou, et al.. (2005). Amifostine and Dexrazoxane Enhance the Rapid Loss of Bone Mass and Further Deterioration of Vertebrae Architecture in Female Rats. Calcified Tissue International. 77(3). 175–179. 4 indexed citations

14.

Colby-Germinario, Susan P., et al.. (2004). Short Communication: Antiretroviral Protease Inhibitors Prevent L6 Muscle Cell Fusion by Reducing Calpain Activity. AIDS Research and Human Retroviruses. 20(10). 1057–1062. 3 indexed citations

15.

Servant, Nicolas, Daniela Di Marcantonio, John P.H. Th'ng, & Lorraine E. Chalifour. (2004). TBP-associated factor 1 overexpression induces tolerance to Doxorubicin in confluent H9c2 cells by an increase in cdk2 activity and cyclin E expression. Molecular and Cellular Biochemistry. 259(1-2). 71–81. 1 indexed citations

16.

Servant, Nicolas, et al.. (2004). Chronic β-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart. Canadian Journal of Physiology and Pharmacology. 82(3). 167–174. 11 indexed citations

17.

Héon, Stéphanie, Martin Bernier, Nicolas Servant, et al.. (2003). Dexrazoxane does not protect against doxorubicin-induced damage in young rats. American Journal of Physiology-Heart and Circulatory Physiology. 285(2). H499–H506. 26 indexed citations

18.

Marcantonio, Daniela Di, Lorraine E. Chalifour, Moulay A. Alaoui‐Jamali, Lesley Alpert, & Hung Huynh. (2001). Cloning and Characterization of a Novel Gene That Is Regulated by Estrogen and Is Associated with Mammary Gland Carcinogenesis*. Endocrinology. 142(6). 2409–2418. 22 indexed citations

19.

Derjuga, Anna, Christina Richard, Paul S. Wright, et al.. (2001). Expression of p21Waf1/Cip1 and Cyclin D1 Is Increased in Butyrate-resistant HeLa Cells. Journal of Biological Chemistry. 276(41). 37815–37820. 16 indexed citations

20.

Chalifour, Lorraine E.. (1991). Overview: Recent Aspects of Transgene Technology. 1(12). 1821–1841. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact